Duration of benefit following completion of pulmonary rehabilitation in interstitial lung disease-an observational study

被引:10
作者
Sharp, C. [1 ,2 ]
McCabe, M. [3 ]
Hussain, M. J. [1 ]
Dodd, J. W. [2 ]
Lamb, H. [1 ]
Adamali, H. [1 ]
Millar, A. B. [2 ]
Smith, D. [1 ]
机构
[1] Southmead Hosp, North Bristol Lung Ctr, Bristol BS10 5NB, Avon, England
[2] Univ Bristol, Southmead Hosp, Acad Resp Grp, Learning & Res Bldg, Bristol BS10 5NB, Avon, England
[3] London Sch Econ, Dept Geog, Houghton St, London WC2A 2AE, England
关键词
QUALITY-OF-LIFE; EXERCISE CAPACITY; IMPROVEMENT; PREDICTORS; ENDURANCE; SYMPTOMS; EFFICACY; OUTCOMES;
D O I
10.1093/qjmed/hcw105
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: It remains unclear for how long the benefits of pulmonary rehabilitation (PR) last in interstitial lung disease (ILD). An increasing number of ILD patients complete PR and it is vital they be offered the most beneficial approaches. Methods: This is a retrospective, observational study of a cohort with ILD who had completed PR. Incremental shuttle walk (ISWT) and chronic respiratory disease questionnaire (CRDQ) were compared before PR, at course completion, and 6/12 months follow-up. Focus group discussions with ILD participants who had completed PR and their carers established qualitative views on existing and potential future PR provision. Results: 79 participants with ILD were identified at course completion, with 39 followed to 12 months. 11 participants died during follow-up. Initial benefits from PR were not sustained at 6 months (ISWT change 0.0m (95% CI-23.2 to 23.2 m), CRDQ change 2.5 (95% CI-2.4 to 7.4)) and 12 months (ISWT change-0.7 m (95% CI-37.3 to 35.9 m), CRDQ change 4.0 (95% CI-2.2 to 10.2)). Continued home exercise gave longer lasting benefit in exercise capacity. Focus group discussions highlighted the value attached to PR and suggested areas for improvement. Conclusions: Standard PR gives initial benefits in participants with ILD who complete the course, however these are not sustained. Tailored approaches to this group would be appreciated by this group and should be explored.
引用
收藏
页码:17 / 22
页数:6
相关论文
共 31 条
[21]   Long-Term Efficacy of Pulmonary Rehabilitation in Patients with Occupational Respiratory Diseases [J].
Ochmann, Uta ;
Kotschy-Lang, Nicola ;
Raab, Wolfgang ;
Kellberger, Jessica ;
Nowak, Dennis ;
Joerres, Rudolf A. .
RESPIRATION, 2012, 84 (05) :396-405
[22]   Assessing the minimal important difference in symptoms: A comparison of two techniques [J].
Redelmeier, DA ;
Guyatt, GH ;
Goldstein, RS .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (11) :1215-1219
[23]   Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis [J].
Richeldi, Luca ;
du Bois, Roland M. ;
Raghu, Ganesh ;
Azuma, Arata ;
Brown, Kevin K. ;
Costabel, Ulrich ;
Cottin, Vincent ;
Flaherty, Kevin R. ;
Hansell, David M. ;
Inoue, Yoshikazu ;
Kim, Dong Soon ;
Kolb, Martin ;
Nicholson, Andrew G. ;
Noble, Paul W. ;
Selman, Moises ;
Taniguchi, Hiroyuki ;
Brun, Michele ;
Le Maulf, Florence ;
Girard, Mannaig ;
Stowasser, Susanne ;
Schlenker-Herceg, Rozsa ;
Disse, Bernd ;
Collard, Harold R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22) :2071-2082
[24]   Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: A prospective cohort study [J].
Ryerson, Christopher J. ;
Cayou, Cindy ;
Topp, Fiona ;
Hilling, Lana ;
Camp, Pat G. ;
Wilcox, Pearce G. ;
Khalil, Nasreen ;
Collard, Harold R. ;
Garvey, Chris .
RESPIRATORY MEDICINE, 2014, 108 (01) :203-210
[25]   The role of biologics in treatment of connective tissue disease-associated interstitial lung disease [J].
Sharp, C. ;
Dodds, N. ;
Mayers, L. ;
Millar, A. B. ;
Gunawardena, H. ;
Adamali, H. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2015, 108 (09) :683-688
[26]   An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation [J].
Spruit, Martijn A. ;
Singh, Sally J. ;
Garvey, Chris ;
ZuWallack, Richard ;
Nici, Linda ;
Rochester, Carolyn ;
Hill, Kylie ;
Holland, Anne E. ;
Lareau, Suzanne C. ;
Man, William D. -C. ;
Pitta, Fabio ;
Sewell, Louise ;
Raskin, Jonathan ;
Bourbeau, Jean ;
Crouch, Rebecca ;
Franssen, Frits M. E. ;
Casaburi, Richard ;
Vercoulen, Jan H. ;
Vogiatzis, Ioannis ;
Gosselink, Rik ;
Clini, Enrico M. ;
Effing, Tanja W. ;
Maltais, Francois ;
van der Palen, Job ;
Troosters, Thierry ;
Janssen, Daisy J. A. ;
Collins, Eileen ;
Garcia-Aymerich, Judith ;
Brooks, Dina ;
Fahy, Bonnie F. ;
Puhan, Milo A. ;
Hoogendoorn, Martine ;
Garrod, Rachel ;
Schols, Annemie M. W. J. ;
Carlin, Brian ;
Benzo, Roberto ;
Meek, Paula ;
Morgan, Mike ;
Rutten-van Moelken, Maureen P. M. H. ;
Ries, Andrew L. ;
Make, Barry ;
Goldstein, Roger S. ;
Dowson, Claire A. ;
Brozek, Jan L. ;
Donner, Claudio F. ;
Wouters, Emiel F. M. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (08) :E13-E64
[27]   Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives [J].
Swigris J.J. ;
Stewart A.L. ;
Gould M.K. ;
Wilson S.R. .
Health and Quality of Life Outcomes, 3 (1)
[28]   Long-Term Effects of a 12-Week Exercise Training Program on Clinical Outcomes in Idiopathic Pulmonary Fibrosis [J].
Vainshelboim, Baruch ;
Oliveira, Jose ;
Fox, Benjamin Daniel ;
Soreck, Yafit ;
Fruchter, Oren ;
Kramer, Mordechai Reuven .
LUNG, 2015, 193 (03) :345-354
[29]   Quadriceps weakness contributes to exercise capacity in nonspecific interstitial pneumonia [J].
Watanabe, Fumiko ;
Taniguchi, Hiroyuki ;
Sakamoto, Koji ;
Kondoh, Yasuhiro ;
Kimura, Tomoki ;
Kataoka, Kensuke ;
Ogawa, Tomoya ;
Arizono, Shinichi ;
Nishiyama, Osamu ;
Hasegawa, Yoshinori .
RESPIRATORY MEDICINE, 2013, 107 (04) :622-628
[30]   Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish thoracic society [J].
Wells, A. U. ;
Hirani, N. .
THORAX, 2008, 63 :v1-v58